Loading...
Header Logo
Keywords
Last Name
Institution

Victoria Christiansen

TitleProf,Asst of Research
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentRheumatology/Immunology/Allerg
Phone405/271-3920
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jackson KW, Christiansen VJ, Yadav VR, Silasi-Mansat R, Lupu F, Awasthi V, Zhang RR, McKee PA. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase. Neoplasia. 2015 Jan; 17(1):43-54. PMID: 25622898; PMCID: PMC4309729.
      View in: PubMed, PubMed Central
    2. Christiansen VJ, Jackson KW, Lee KN, Downs TD, McKee PA. Targeting inhibition of fibroblast activation protein-a and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments. Neoplasia. 2013 Apr; 15(4):348-58. PMID: 23555181; PMCID: PMC3612908.
      View in: PubMed, PubMed Central
    3. Lee KN, Jackson KW, Terzyan S, Christiansen VJ, McKee PA. Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design. Biochemistry. 2009 Jun 16; 48(23):5149-58. PMID: 19402713; PMCID: PMC4470291.
      View in: PubMed, PubMed Central
    4. Narra K, Mullins SR, Lee HO, Strzemkowski-Brun B, Magalong K, Christiansen VJ, McKee PA, Egleston B, Cohen SJ, Weiner LM, Meropol NJ, Cheng JD. Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. Cancer Biol Ther. 2007 Nov; 6(11):1691-9. PMID: 18032930.
      View in: PubMed
    5. Christiansen VJ, Jackson KW, Lee KN, McKee PA. The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity. Blood. 2007 Jun 15; 109(12):5286-92. PMID: 17317851; PMCID: PMC1890835.
      View in: PubMed, PubMed Central
    6. Christiansen VJ, Jackson KW, Lee KN, McKee PA. Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV. Arch Biochem Biophys. 2007 Jan 15; 457(2):177-86. PMID: 17174263; PMCID: PMC1857293.
      View in: PubMed, PubMed Central
    7. Lee KN, Jackson KW, Christiansen VJ, Lee CS, Chun JG, McKee PA. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood. 2006 Feb 15; 107(4):1397-404. PMID: 16223769.
      View in: PubMed
    8. Lee KN, Jackson KW, Christiansen VJ, Chung KH, McKee PA. Alpha2-antiplasmin: potential therapeutic roles in fibrin survival and removal. Curr Med Chem Cardiovasc Hematol Agents. 2004 Oct; 2(4):303-10. PMID: 15320781.
      View in: PubMed
    9. Lee KN, Jackson KW, Christiansen VJ, Chung KH, McKee PA. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion. Blood. 2004 May 15; 103(10):3783-8. PMID: 14751930.
      View in: PubMed
    Christiansen's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (69) concept(s)
    _
    Co-Authors Expand Description
    See all (4) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department